DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease

Clinical trial NCT00440050 · COMPLETED

Trial details

NCT number: NCT00440050
Sponsor: Alzheimer's Disease Cooperative Study (ADCS)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer's Disease

Start date: 2007-02-01
Primary completion: 2009-05-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.